The more i dig the more excited i get
Pab does not just have dx-1 but also sm6 which is the much more advanced project
they are looking for partner for this project
Partnership could be with global majors like
Amgen (138bn company)
Celgene (110bn company)
Or the other option is to do it all alone and raise capital
I think any sniff of a partnership with AMGEN to commercialise sm6 could make PAB a very significant company
All dreams but can happen
Traderrr
Ann: PAT-DX1 Active in Pre-clinical Cancer Models, page-114
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1283356 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 4958674 | 5 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable